Table 1.
Subject cohorts details
| Pediatric COVID-19 | Adults COVID-19 | Negative | ||||||
|---|---|---|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | ||||||
| Patients | Samples | 254 | 36 | 33 | ||||
| Individuals | 122 | 36 | 33 | |||||
| Symptoms | Asymptomatic | 44 (36%) | 9 (25%) | - | ||||
| Mild/Severe | 78/0 | 25/1 | - | |||||
| Age | Mean±stdev | 10.8 ± 4.9 years | Mean±stdev | 34 ± 17.1 years | Mean±stdev | 29.3 ± 16.3 years | ||
| 0–8 years | 45 (37%) | Median | 31 | Adults (N=13) | 30 – 65 | |||
| 8–12 years | 33 (27%) | Min | 18 | Pediatrics (N=20) | 11 – 18 | |||
| 12–18 years | 44 (36%) | Max | 71 | |||||
| Gender | Female | 49 (40%) | 10 (28%) | 17 (51%) | ||||
| Male | 73 (60%) | 26 (72%) | 16 (49%) | |||||